Carson Wealth (CWM LLC)’s 9 Meters Biopharma NMTR Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio NMTR Stock Details NMTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-6	Closed	–	–	4453
2022 Q4	$0	Buy	+6	New	+$14	﹤0.01%	4358

Other funds holding NMTR

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ODFS

O'Donnell Financial Services San Rafael, California $290M AUM 15.6% 1-Year Est. Return

CIBC Asset Management Toronto, Ontario, Canada $40.9B AUM 35.96% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Carson Wealth (CWM LLC)'s NMTR Position: Q1 2023 in Review

Carson Wealth (CWM LLC) sold out of 9 Meters Biopharma (NMTR) in Q1 2023, closing a stake of 6 shares.

Carson Wealth (CWM LLC) first reported a position in NMTR in Q4 2022 and held it in 1 quarter. The position peaked at $0 in Q4 2022. 39 funds tracked by Wall St. Rank hold NMTR as of Q1 2023.

Carson Wealth (CWM LLC) reported no remaining 9 Meters Biopharma position as of Q1 2023 after selling out during the quarter.
Carson Wealth (CWM LLC) sold 6 9 Meters Biopharma shares in Q1 2023.
Carson Wealth (CWM LLC) first reported a position in 9 Meters Biopharma in Q4 2022 and held it in 1 quarter.
Carson Wealth (CWM LLC)'s 9 Meters Biopharma position peaked at $0 in Q4 2022.
39 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q1 2023.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2023, filed 1 May 2023.